Ajanta Pharma (AJANTPHARM.BO) Earnings Analysis
Ajanta Pharma (AJANTPHARM.BO) next reports earnings on 2026-07-30, consensus EPS 23.04 INR. Last quarter (2026-01-30) it beat with EPS 21.91 INR vs 19.83 INR est (+10.5%). It has beaten estimates in 4/6 recent quarters (67%). Trailing P/E 40.93.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does AJANTPHARM.BO next report earnings?
| Next earnings date | 2026-07-30 |
|---|---|
| Consensus EPS estimate | 23.04 INR |
| Revenue estimate | 15.04B |
AJANTPHARM.BO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-01-30 | 21.91 INR | 19.83 INR | +10.5% | Beat |
| 2025-10-27 | 20.8 INR | 20.54 INR | +1.3% | Beat |
| 2025-07-27 | 20.43 INR | 19.65 INR | +4% | Beat |
| 2025-05-02 | 18 INR | 19.7 INR | -8.6% | Miss |
| 2025-01-29 | 18.59 INR | 17.5 INR | +6.2% | Beat |
| 2024-10-27 | 17.26 INR | 17.7 INR | -2.5% | Miss |
Beat rate: 4/6 (67%) over reported quarters with consensus data.
AJANTPHARM.BO valuation and analyst view
| Trailing P/E | 40.93 |
|---|---|
| Trailing EPS | 84.535 INR |
| Price / book | 9.55 |
| Dividend yield | 0.81% |
| Market cap | 431.89B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Ajanta Pharma (AJANTPHARM.BO)'s next earnings date?
Ajanta Pharma is next scheduled to report on 2026-07-30, with a consensus EPS estimate of 23.04 INR and revenue estimate of 15.04B.
Did AJANTPHARM.BO beat earnings last quarter?
In its 2026-01-30 report, AJANTPHARM.BO posted EPS of 21.91 INR versus a 19.83 INR estimate — a beat of 10.5%.
What is AJANTPHARM.BO's earnings track record?
Over the last 6 reported quarters with consensus data, AJANTPHARM.BO beat estimates 4 times (67%).
What is AJANTPHARM.BO's current P/E ratio and EPS?
AJANTPHARM.BO trades at a trailing P/E of 40.93 on trailing EPS of 84.53545525864968 INR.
What do analysts rate AJANTPHARM.BO?
AJANTPHARM.BO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.